Cornerstone Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for CORNERSTONE, and what generic and branded alternatives to CORNERSTONE drugs are available?
CORNERSTONE has two approved drugs.
Drugs and US Patents for Cornerstone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cornerstone | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 076750-001 | Jun 28, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Cornerstone | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 076743-001 | May 7, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.